MorphoSys Announces First Scientific Publication on Novel Antibody Platform Ylanthia

News   May 13, 2013

 
MorphoSys Announces First Scientific Publication on Novel Antibody Platform Ylanthia
 
 
 

RELATED ARTICLES

Scleroderma Study Offers New Hope For Sufferers

News

An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study found. The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.

READ MORE

Cold and Flu Season is Well Under Way But Don't Stifle a Sneeze Warn Doctors

News

Pinching your nose while clamping your mouth shut to contain a forceful sneeze isn't a good idea, warn doctors. One young man managed to rupture the back of his throat during this manoeuvre, leaving him barely able to speak or swallow, and in considerable pain.

READ MORE

Immunosuppressive Cells in Newborns Play Important Role in Controlling Inflammation in Early Life

News

New research has characterized the transitory presence of myeloid-derived suppressor cells (MDSCs) in mouse and human newborns, revealing a critical role of these cells in regulation of inflammation in the early stages of life.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE